Table 3.
Research subjects | Exercise program | Changes in endothelial-function test indicators | Literature sources | ||||
Intensity | Duration and frequency of exercise | Forms | Indicators | Values (before vs. after exercsie) | Change | ||
Healthy young men (n = 10) | 85% | One time, 30 min | Cycling | FMD | 6.6 1.6 vs. 3.6 2.2% | (↓) p 0.05 | [27] |
Young men (n = 9) | extreme sports | One time | Ironman triathlon | FMD | 8.7 vs. 3.2% | (↓) p 0.05 | [41] |
Sedentary middle-aged men (n = 11) | 80% 1RM | One time, 40 min | Resistance exercise | ET-1 | 20.02 2.2 vs. 25.4 2.1 pg/mL | (↓) p = 0.004 | [30] |
Healthy young men (n = 8) | 75% | 30 min/d, 5–7 times/w, 12 w | Cycling | 8-OHdG | 6.7 1.1 vs. 9.2 2.3 ng/mL | (↑) p 0.05 | [9] |
MDA-LDL | 69.0 19.5 vs. 82.4 21.5 U/L | (↑) p 0.05 | |||||
Patients with hypertensive metabolic syndrome (n = 17) | 40% HRR 5 min, 60% HRR 5 min, 80% HRR5 min, recovery 40% HRR 5 min (HIIT) | 3 d/w, 8 w | Treadmill running | FMD | 6.5 4.2 vs. 12.6 6.0% | (↑) p 0.05 | [43] |
38.5 21.41 vs. 50.89 20.92 mmol/L | (↑) p 0.05 | ||||||
Healthy elderly (n = 12) | 100% PPO, recovery 15 s, 2 × 20 min/time (HIIT) | 3 d/w, 6 w | Cycling | FMD | 4.8 1.8 vs. 6.7 1.3% | (↑) p 0.001 | [42] |
Patients with type 1 diabetes (n = 12) | 60% 5 min, 85% 1 min × 6 times, 50% 4 min (HIIT) | 40 min/d, 3 d/w, 8 w | Cycling | FMD | 5.7 5.0 vs. 11.2 5.4% | (↑) p 0.05 | [46] |
C57BL/6 mice (n = 6) | Started at 5 m/min and increased by 4 m/min every 10 min until exhaution | One time | Treadmill training | NO | (↓) p 0.01 | [44] | |
Three-month-old SHR (n = 8) | 26–28 m/min | 60 min/d, 5 d/w, 8 w | Treadmill training | ROS | (↑) p 0.05 | [35] | |
NO | (↓) p 0.05 | ||||||
Ten-week-old SHR rats (n = 24) | 80% | 1 h/d, 5 d/w, 6 w | Treadmill training | ROS | (↑) p 0.05 | [12] | |
NO | (↓) p 0.05 | ||||||
Eight-week-old Zucker rats (n = 12) | 10 m/min (3 min) and 18 m/min (4 min) alternating 6 sets | 5 d/w, 10 w | Treadmill training | SOD | 5.82 0.74 vs. 7.13 0.51 µmol· | (↑) p 0.05 | [45] |
GPx | 2.09 0.90 vs. 3.29 1.38 µmol· | (↑) p 0.05 |
indicates increase, indicates decrease. , maximal heart rate; FMD, flow-mediated dilatation; ET-1, endothelin-1; 8-OHdG, 8-hydroxy-2 deoxyguanosine; HRR, heart rate in reserve; HIIT, high-intensity interval training; MDA-LDL, malondialdehyde-low density lipoprotein; NO, nitric oxide; ROS, reactive oxygen species; , maximal oxygen uptake; SOD, superoxide dismutase; GPx, glutathione peroxidase; 1RM, one-repetition maximum; PPO, peak power ouput; h/d, hour/day; d/w, day/week; , nitrites and nitrates.